BANCA IFISSPA financials
BANCA IFISSPA
8156005420362AE59184 ISIN: IT0003188064 | Line item | 2023 | 2022 |
|---|---|---|
| Income statement | ||
| Administrative expenses | €424.7M | €393.3M |
| Profit before tax | €237.6M | €211.8M |
| Income tax expense | €75.6M | €69.9M |
| Profit for the year | €161.9M | €141.9M |
| — attributable to owners | €160.1M | €141.1M |
| — attributable to NCI | -€1.8M | -€801.0K |
| Total comprehensive income | €177.2M | €106.6M |
| Cash flow statement | ||
| Cash generated from operations | €180.1M | €158.8M |
| Net cash from operating activities | €445.4M | €400.0M |
| Net cash from investing activities | -€105.9M | -€17.5M |
| Purchase of intangibles | €20.4M | €10.1M |
| Net cash from financing activities | -€85.2M | -€134.7M |
| Dividends paid | €85.2M | €102.5M |
| Net change in cash | €254.4M | €247.8M |
| Balance sheet | ||
| Total assets | €14.05B | €13.26B |
| Intangible assets & goodwill | €76.7M | €64.3M |
| Cash & equivalents | €857.5M | €603.1M |
| Non-controlling interests | €14.2M | €12.4M |
| Deferred tax liabilities | €31.7M | €30.3M |
| Derived metrics | ||
| Cash conversion ratio | 2.75× | 2.82× |
| Other reported items | ||
| Adjustments For Decrease Increase In Financial Assets Held For Trading | -€4.1M | €3.1M |
| Adjustments For Increase Decrease In Financial Liabilities Held For Trading | -€12.0M | -€921.0K |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €63.1M | €0 |
| Comprehensive Income Attributable To Noncontrolling Interests | -€1.8M | -€797.0K |
| Comprehensive Income Attributable To Owners of Parent | €175.4M | €105.8M |
| Current Tax Assets | €46.6M | €60.9M |
| Current Tax Liabilities | €26.0M | €22.0M |
| Debt Securities | €3.29B | €2.61B |
| Deferred Tax Assets | €238.8M | €264.3M |
| Deposits From Banks | €2.72B | €3.42B |
| Deposits From Customers | €5.81B | €5.10B |
| Derivative Financial Liabilities Held For Hedging | €11.6M | €0 |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | €0 | €0 |
| Equity and Liabilities | €14.05B | €13.26B |
| Fee and Commission Expense | €14.1M | €13.0M |
| Fee and Commission Income | €112.3M | €106.5M |
| Fee and Commission Income Expense | €98.2M | €93.5M |
| Financial Assets At Amortised Cost | €11.26B | €10.75B |
| Financial Assets At Fair Value Through Profit Or Loss | €234.9M | €222.1M |
| Financial Assets At Fair Value Through Profit Or Loss Classified As Held For Trading | €12.9M | €26.9M |
| Financial Assets At Fair Value Through Profit Or Loss Mandatorily Measured At Fair Value | €222.0M | €195.2M |
| Financial Assets Measured At Fair Value Through Other Comprehensive Income | €749.2M | €697.6M |
| Financial Liabilities At Amortised Cost | €11.82B | €11.13B |
| Financial Liabilities At Fair Value Through Profit Or Loss Classified As Held For Trading | €14.0M | €26.0M |
| Gains Losses On Disposals of Investments | €986.0K | €304.0K |
| Impairment Loss Impairment Gain and Reversal of Impairment Loss Determined In Accordance With IFRS9 | -€79.3M | -€54.3M |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | €2.0K | -€13.4M |
| Increase Decrease Through Sharebased Payment Transactions | €1.1M | €755.0K |
| Increase Decrease Through Treasury Share Transactions | €0 | -€19.3M |
| Interest Revenue Calculated Using Effective Interest Method | €768.0M | €524.2M |
| Investment Accounted For Using Equity Method | €24.0K | €0 |
| Issue of Equity | €341.0K | €0 |
| Issued Capital | €53.8M | €53.8M |
| Loans and Advances To Banks | €637.6M | €565.8M |
| Loans and Advances To Customers | €10.62B | €10.19B |
| Other Adjustments To Reconcile Profit Loss | €975.0K | €931.0K |
| Other Assets | €444.7M | €471.1M |
| Other Cash Receipts From Sales of Equity Or Debt Instruments of Other Entities Classified As Investing Activities | €0 | €12.0K |
| Other Comprehensive Income | €15.3M | -€35.3M |
| Other Comprehensive Income Net of Tax Gains Losses From Investments In Equity Instruments | -€4.5M | -€3.7M |
| Other Comprehensive Income Net of Tax Gains Losses On Remeasurements of Defined Benefit Plans | -€95.0K | €1.1M |
| Other Comprehensive Income That Will Be Reclassified To Profit Or Loss Net of Tax | €19.8M | -€32.7M |
| Other Comprehensive Income That Will Not Be Reclassified To Profit Or Loss Net of Tax | -€4.6M | -€2.6M |
| Other Liabilities | €387.6M | €391.7M |
| Other Operating Income Expense | €33.6M | €19.8M |
| Provisions | €58.2M | €56.2M |
| Revenue From Dividends | €16.2M | €9.9M |
| Share Premium | €84.1M | €83.8M |
| Trading Income Expense | -€5.3M | €627.0K |
| Treasury Shares | €21.8M | €22.1M |
Every line item above is a fact tagged in BANCA IFISSPA's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.